Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Baxter
Accenture
Argus Health
McKesson
McKinsey
Teva
Healthtrust
Chubb

Generated: December 19, 2018

DrugPatentWatch Database Preview

Patent Applications for SUTENT

« Back to Dashboard

US Patent Applications for SUTENT

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
➤ Try a Free Trial ➤ Try a Free Trial METHODS OF MODULATING C-KIT TYROSINE PROTEIN KINASE FUNCTION WITH INDOLINONE COMPOUNDS 2000-12-22 Abandoned -- Failure to Pay Issue Fee 2003-07-23
➤ Try a Free Trial ➤ Try a Free Trial PRODRUGS OF A 3-(PYRROL-2-YLMETHYLIDENE)-2-INDOLINONE DERIVATIVES 2002-04-09 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2008-10-27
➤ Try a Free Trial ➤ Try a Free Trial PROCESS FOR PREPARING INDOLINONE DERIVATIVES 2003-02-14 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2010-11-08
➤ Try a Free Trial ➤ Try a Free Trial ONCOKINASE FUSION POLYPEPTIDES ASSOCIATED WITH HYPERPROLIFERATIVE AND RELATED DISORDERS, NUCLEIC ACIDS ENCODING THE SAME AND METHODS FOR DETECTING AND IDENTIFYING THE SAME 2003-08-08 Patented Case 2007-03-07
➤ Try a Free Trial ➤ Try a Free Trial Pyrrole substituted 2-indolinone protein kinase inhibitors 2003-04-14 Abandoned -- Failure to Respond to an Office Action 2005-04-15
➤ Try a Free Trial ➤ Try a Free Trial PRODRUGS OF A 3-(PYRROL-2-YLMETHYLIDENE)-2-INDOLINONE DERIVATIVES 2004-04-05 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2010-06-28
US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Federal Trade Commission
Cantor Fitzgerald
McKinsey
Express Scripts
Cipla
Dow
Johnson and Johnson
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.